Minerva Neurosciences, Inc.
Company Stats
- Market Cap
- $160.0M
- as of Sep 30, 2026
- Shares Outstanding
- 47.7M
- Free Float
- 85.0%
Income Statement
- Operating Income
- -$15.1M
- Net Income
- -$293.4M
- EBITDA
- -$15.1M
Balance Sheet
- Cash & Equivalents
- $82.3M
Returns & Capital
- SBC, 3Y Avg
- $1.5M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2024 | $0 | — | — |
| FY2023 | $0 | — | — |
| FY2022 | $0 | -$24.7M | — |
| FY2021 | $0 | — | — |
Annual filing data through FY ended December 31, 2025; shares and float as of November 1, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back